Position in SKYE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$968,774
-$119,204 QoQ
Shares Held
1,575,243
+8.6% QoQ
Ownership
4.48%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SKYE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. SKYE ranks #73 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,744,412 | $2,893,664,057 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,799,053 | $2,613,054,769 | |
| 3 | INSM |
INSMED Inc
|
7,421,111 | $1,213,500,070 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,141,701 | $1,121,116,222 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,896,690 | $954,880,319 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
9,555,357 | $929,258,468 | |
| 7 | CELC |
Celcuity Inc.
|
7,915,792 | $903,508,498 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
19,919,186 | $759,319,370 |
All Filings in SKYE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $968,774 | 1,575,243 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,087,978 | 1,450,638 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,701,007 | 1,450,638 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,063,666 | 1,450,638 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,306,514 | 1,450,638 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,105,305 | 1,450,638 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,609,418 | 1,434,634 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,005,000 | 500,000 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||